These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28716439)

  • 1. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
    Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
    Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
    Lai JZ; Lai HH; Cao D
    Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.
    Gupta R; Billis A; Shah RB; Moch H; Osunkoya AO; Jochum W; Hes O; Bacchi CE; de Castro MG; Hansel DE; Zhou M; Vankalakunti M; Salles PG; Cabrera RA; Gown AM; Amin MB
    Am J Surg Pathol; 2012 Sep; 36(9):1265-78. PubMed ID: 22895263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
    Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
    Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal medullary carcinoma in a young mixed-race man in Japan.
    Toriyama A; Izumi H; Tomita S; Nagashima Y; Ueda Y; Aoki Y; Tsujimura A; Yao T; Hino O
    Pathol Int; 2019 Apr; 69(4):241-245. PubMed ID: 30843648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
    Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
    Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
    Lam ET; Kessler ER; Flaig TW; La Rosa FG
    Oncology (Williston Park); 2013 Sep; 27(9):893, 896, 898. PubMed ID: 24282987
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
    Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
    Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis.
    Singh JA; Ohe C; Smith SC
    Pathol Int; 2018 May; 68(5):265-277. PubMed ID: 29665139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.
    Lebenthal JM; Kontoyiannis PD; Hahn AW; Lim ZD; Rao P; Cheng JP; Chan B; Daw NC; Sheth RA; Karam JA; Tang C; Tannir NM; Msaouel P
    Eur Urol Oncol; 2024 Jul; ():. PubMed ID: 39013742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology of metastatic renal medullary carcinoma in pleural effusion: a study of two cases.
    Ellis CL; Burroughs F; Michael CW; Li QK
    Diagn Cytopathol; 2009 Nov; 37(11):843-8. PubMed ID: 19526572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1/INI1 inactivation in renal medullary carcinoma.
    Calderaro J; Moroch J; Pierron G; Pedeutour F; Grison C; Maillé P; Soyeux P; de la Taille A; Couturier J; Vieillefond A; Rousselet MC; Delattre O; Allory Y
    Histopathology; 2012 Sep; 61(3):428-35. PubMed ID: 22686875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.
    Sandberg JK; Mullen EA; Cajaiba MM; Smith EA; Servaes S; Perlman EJ; Geller JI; Ehrlich PF; Cost NG; Dome JS; Fernandez CV; Khanna G
    Pediatr Radiol; 2017 Nov; 47(12):1615-1621. PubMed ID: 28689245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Renal Medullary Carcinoma.
    Su Y; Hong AL
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC with possible clinical significance.
    Montironi R; Lopez-Beltran A; Cheng L; Galosi AB; Montorsi F; Scarpelli M
    Eur Urol; 2014 Nov; 66(5):806-10. PubMed ID: 24821578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
    Jia L; Carlo MI; Khan H; Nanjangud GJ; Rana S; Cimera R; Zhang Y; Hakimi AA; Verma AK; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Gartrell BA; Chen YB
    Mod Pathol; 2019 Sep; 32(9):1329-1343. PubMed ID: 30980040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.